Showing results (111-120 of 154) with videos related to

Sort By:
Pageof 16
Danish Medical Journal|March 3, 2012
Systemic mastocytosis--a systematic reviewChristen Lykkegaard Andersen, Thomas Kielsgaard Kristensen, Marianne Tang Severinsen, et al.
Plos One|November 15, 2014
Whole blood transcriptional profiling reveals deregulation of oxidative and antioxidative defence genes in myelofibrosis and related neoplasms. Potential implications of downregulation of Nrf2 for genomic instability and disease progressionHans Carl Hasselbalch, Mads Thomassen, Caroline Hasselbalch Riley, et al.
Hematology (Amsterdam, Netherlands)|November 28, 2009
Minimal residual disease and normalization of the bone marrow after long-term treatment with alpha-interferon2b in polycythemia vera. A report on molecular response patterns in seven patients in sustained complete hematological remissionThomas Stauffer Larsen, Michael Boe Møller, Karin de Stricker, et al.
Thrombosis and Haemostasis|December 23, 2025
Atrial Fibrillation in Philadelphia Chromosome-negative Myeloproliferative Neoplasms: Thromboinflammatory Crosstalk with a Focus on the NLRP3 InflammasomeOlga Demska, Marta Szandruk-Bender, Niels Eske Bruun, et al.
Thrombosis Research|December 9, 2024
Thromboinflammation in ischemic cerebrovascular patients with the JAK2V617F mutationMarie Hvelplund Kristiansen, Morten Kranker Larsen, Laura Massarenti, et al.
European Journal of Haematology|December 12, 2003
Elevated plasma levels of TIMP-1 correlate with plasma suPAR/uPA in patients with chronic myeloproliferative disordersMorten Krogh Jensen, Mads Nikolai Holten-Andersen, Rikke Riisbro, et al.
Clinical Epidemiology|November 9, 2016
The Danish National Chronic Myeloid Neoplasia RegistryMarie Bak, Else Helene Ibfelt, Thomas Stauffer Larsen, et al.
European Journal of Haematology|June 29, 2026
Platelet Counts During Pregnancy as Predictor of Subsequent Myeloproliferative NeoplasmFreja Rueholm Klok, Katrine Jeong Jørgensen, Morten Kranker Larsen, et al.
Cancers|September 9, 2023
Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related NeoplasmsHans Carl Hasselbalch, Peter Junker, Vibe Skov, et al.
Ugeskrift for Laeger|March 15, 2019
[Cancer immune therapy for the treatment of haematological malignancies]Morten Orebo Holmström, Uffe Klausen, Nicolai Grønne Jørgensen, et al.
Pageof 16